A Preliminary Study Of Risk Factors Of Breast Cancer And The Usefulness Of Breast MRI As An Addition To Mammography In Detecting Breast Cancer In High Risk Women by Hashim, Nur Hashamimi
 
 
 
A PRELIMINARY STUDY OF RISK FACTORS OF 
BREAST CANCER AND THE USEFULNESS OF 
BREAST MRI AS AN ADDITION TO 
MAMMOGRAPHY IN DETECTING BREAST 
CANCER IN HIGH RISK WOMEN 
 
 
 
 
 
 
 
NUR HASHAMIMI BINTI HASHIM 
 
 
 
 
 
 
 
UNIVERSITI SAINS MALAYSIA 
2016 
 
 
 
A PRELIMINARY STUDY OF RISK FACTORS OF 
BREAST CANCER AND THE USEFULNESS OF 
BREAST MRI AS AN ADDITION TO 
MAMMOGRAPHY IN DETECTING BREAST 
CANCER IN HIGH RISK WOMEN 
 
 
 
 
 
By 
 
 
 
 
NUR HASHAMIMI BINTI HASHIM 
 
 
Dissertation Submitted in Partial Fulfilment of The 
Requirements for The Degree of Master Of Science 
 
 
 
 
Universiti Sains Malaysia 
January 2016
i 
 
DECLARATION 
 
I certify that this thesis does not incorporate without acknowledgement any material 
previously submitted for a master, degree or diploma in any university; and that to the 
best of my knowledge and belief it does not contain any material previously published 
or written by another person except where due reference is made in the text. This is to 
certify that the dissertation entitled “A Preliminary Study of Risk Factors of Breast 
Cancer and the Usefulness of MRI as an Addition to Mammography in detecting 
Breast Cancer in High Risk Women” is the bona fide record of research work done 
by Nur Hashamimi Binti Hashim, Matric Number P-IPM0022/15 during the period of 
February 2015 until January 2016. This dissertation is submitted in partial fulfilment for 
the degree of Master of Science (Medical Research). Research work and collection of 
data belong to Universiti Sains Malaysia. 
 
 
………………………………………..  
Nur Hashamimi Binti Hashim  
Master of Science (Medical Research), 
Advanced Medical and Dental Institute, 
UniversitiSains Malaysia,  
Bertam, 
13200 Kepala Batas, 
Pulau Pinang. 
Date : 
ii 
 
ACKNOWLEDGEMENT 
In the Name of ALLAH the Most Gracious and Merciful 
       I would like to express my gratitude to ALLAH swt as He has given me the 
strength and guidance for completing the research and dissertation successfully.  
            A special thanks to my supervisor, Dr. Noor Khairiah A. Karim for her 
continuous guidance, support and supervision throughout my research project. I also 
would like to express my gratitude to my co-supervisor, Prof. Dr. Ibrahim Lutfi Shuaib 
for his willingness to share his valuable experience and time.  
 I am also indebted to Pn Meszaida, officer from unit records of AMDI for her 
time to sort out the patients’ data and record. I sincerely appreciate her effort in helping 
me along the record retrieval for my research project. Thousand thanks to En Nizuwan, 
statistician at AMDI for his untiring guidance for the statistical analysis of my study. 
Besides that, I also would like to thank to Dr Rohayu Hami for her precious time to 
provide me with the materials that could help me during my statistical analysis. Only 
Allah swt can repay their goodness and kindness. 
         In addition, I would like to express my deepest appreciation towards all my family 
members especially my parents, Hashim Bin Salleh and Minah Binti Hamid that have 
given their endless moral support, financial support, patience and assistant from the 
beginning until the end of my research study. Last but not least, thank you to my best 
friend Siti Fairus Abdul Rahman, for sharing ups and downs in struggling along our 
master journey and toall my colleagues, housemates and roommates who give full 
cooperation and support in completing my research project. Finally, lovely thanks to my 
fiancé Muhammad Tarmizi Anuar, who continuously supported me wherever I am and 
in whatever I do. 
 
Thank you very much.  
 
 
iii 
 
TABLE OF CONTENTS 
 PAGES 
DECLARATION .........................................................................................................i 
ACKNOWLEDGEMENT ......................................................................................... ii 
TABLE OF CONTENTS ......................................................................................... iii 
LIST OF TABLES ...................................................................................................... v 
LIST OF FIGURE .....................................................................................................vi 
LIST OF ABBREVIATIONS ................................................................................. vii 
LIST OF APPENDICES ........................................................................................ viii 
ABSTRACT ................................................................................................................ix 
ABSTRAK ..................................................................................................................xi 
CHAPTER 1 ................................................................................................................ 1 
INTRODUCTION ...................................................................................................... 1 
1.1 Background of the Study ................................................................................. 1 
1.2 Problem Statement ......................................................................................... 2 
1.3 Research objectives ........................................................................................ 4 
1.3.1 General Objective .................................................................................. 4 
1.3.2 Specific Objectives ................................................................................. 4 
1.4 Research Questions ........................................................................................ 4 
1.5 Research Hypothesis ...................................................................................... 4 
1.6 Significance of the Study ................................................................................ 5 
CHAPTER 2 ................................................................................................................ 7 
LITERATURE REVIEW .......................................................................................... 7 
2.1 Introduction ................................................................................................... 7 
2.1.1 Risk factors of Breast Cancer ............................................................................ 8 
2.1.2 Screening tools of Breast Cancer ..................................................................... 10 
2.2 Theoretical Framework ..................................................................................... 12 
CHAPTER 3 .............................................................................................................. 15 
RESEARCH METHODOLOGY ............................................................................ 15 
3.1 Research Design .......................................................................................... 15 
3.2 Population and Setting .................................................................................. 15 
3.3 Sampling plan.............................................................................................. 15 
3.3.1 Sample ................................................................................................... 15 
3.3.1.1 Inclusion Criteria ............................................................................. 15 
3.3.1.2 Exclusion Criteria ............................................................................ 15 
3.3.2 SamplingMethod .................................................................................. 16 
3.3.3 Sample Size ........................................................................................... 16 
3.4 Variable ...................................................................................................... 17 
3.4.1 Variable measurement ......................................................................... 17 
iv 
 
3.5 Instrumentation ............................................................................................ 17 
3.6 Ethical Considerations .................................................................................. 18 
3.7  Data Collection Methods ..................................................................... 18 
3.7.1 Flow chart of Data Collection ............................................................. 19 
3.8 Data Analysis .............................................................................................. 20 
3.9      Definition of Operational Term ..................................................................... 20 
3.9.1 Independent Variables (Risk Factors).................................................... 20 
3.9.2 Dependent Variables ................................................................................ 21 
CHAPTER 4 .............................................................................................................. 23 
RESULTS .................................................................................................................. 23 
4.1 Sociodemographic Data ................................................................................ 23 
4.2 Risk factors of Breast Cancer ............................................................................ 25 
4.2.1 Descriptive Statistic .................................................................................. 25 
4.2.2 Significant risk factors of Breast Cancer ............................................... 27 
4.2.3 Multivariate Analysis (multiple logistic regression analysis) ............... 30 
4.2.4 Model of Fitness test ................................................................................. 31 
4.3 Breast Cancer Diagnostic test ............................................................................ 33 
4.3.1 Selected Socio Demographic Data .......................................................... 33 
4.3.2 Mammography test .................................................................................. 34 
4.3.3 Breast MRI test ......................................................................................... 35 
4.4 Sensitivity and Specificity test of Mammography ................................................ 37 
4.5 Specificity and Sensitivity of Breast MRI ........................................................... 39 
4.6 The usefulness of Breast MRI as an addition to Mammography ............................. 41 
CHAPTER 5 .............................................................................................................. 42 
DISCUSSION ............................................................................................................ 42 
5.1 Introduction ................................................................................................. 42 
5.2 Selected Sociodemographic Data ....................................................................... 42 
5.3 Risk factors of Breast Cancer ............................................................................ 44 
5.4 Screening and Diagnostic test of Breast Cancer detection ..................................... 48 
CHAPTER 6 .............................................................................................................. 51 
CONCLUSION AND RECOMMENDATION ...................................................... 51 
6.1 Summary of the Findings .............................................................................. 51 
6.2 Limitation of the Study ..................................................................................... 52 
6.3 Future Direction .............................................................................................. 52 
REFERENCES .......................................................................................................... 53 
APPENDICES ........................................................................................................... 59 
APPENDIX 1: Permission letter for retrieval of data and records’ patients ................... 59 
APPENDIX 2: Ethical Approval From Human Research Ethics Committee USM ......... 60 
APPENDIX 2: Ethical Approval From Human Research Ethics Committee USM ......... 61 
APPENDIX 2: Ethical Approval From Human Research Ethics Committee USM ......... 62 
APPENDIX 3: Data collection sheet ........................................................................ 63 
 
v 
 
 
 
LIST OF TABLES 
Tables              Pages 
Table 2.1 Key concepts and definition of health belief models   14 
Table 4.1 Frequency and Percentage for selected socio-demographic data 
 (n=289)        25 
Table 4.2 Frequency and percentage of risk factors of breast cancer 
 (n=289)        27 
Table 4.3 Univariate analysis of risk factors of breast cancer (n=289)  28 
Table 4.4 The simple logistic regression analysis of risk factors for  
breast cancer (n=289)       29 
Table 4.5 Multivariate analysis of risk factors of breast cancer (n=289) 30 
Table 4.6 The multiple logistic regression analysis of risk factors for 
breast cancer (n=289)       30 
Table 4.7 The Hosmer-Lemeshow test (n=289)                        31 
Table 4.8 Classification table       31 
Table 4.9 Area under the curve       32 
Table 4.10 Frequency and percentage of selected socio demographic data 
in breast cancer diagnostic test (n=120)    33 
Table 4.11 Frequency and percentage of mammography result (BIRADS)  
(n=120)        34 
Table 4.12 Frequency and percentage of mammography result (n=120)  35 
Table 4.13 Frequency and percentage of breast MRI result (BIRADS) 
 (n=120)        36 
Table 4.14 Frequency and percentage of breast MRI result (n=120)  36 
Table 4.15 Contingency table of mammogram     38 
Table 4.16 Contingency table of breast MRI     40 
Table 4.17 Pearson Chi square test of breast MRI and mammography  41 
Table 4.18 Contingency table of breast MRI and mammography  41 
 
vi 
 
 
LIST OF FIGURE 
Figures         Pages 
Figure 2.1 Theoretical framework of Health Belief Model   13 
Figure 3.1 Flow chart of data collection      19 
Figure 4.1 ROC curve        33 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
vii 
 
LIST OF ABBREVIATIONS 
 
1. AMDI              = Advanced Medical and Dental Institute 
2. BI-RADS  = Breast Imaging Reporting and Data System 
3. BMI   = Body Mass Index 
4. BRCA   = Breast Cancer gene 
5. CI   =  Confidence Interval 
6. HBM   = Health Believe Model 
7. HER2   = Human Epidermal Growth Factor Receptor 2 
8. HPE   = Histopathological Examination 
9. HRT   = Hormone Replacement Therapy 
10. MARIBS  =  Magnetic Resonance Imaging in Breast Screening 
11. MRI   = Magnetic Resonance Imaging 
12. OR   = Odds ratio 
13. p53   = Tumour protein p53 
14. SD   = Standard Deviation 
15. USM   = Universiti Sains Malaysia 
16. WHO   = World Health Organization 
 
 
 
 
viii 
 
LIST OF APPENDICES 
APPENDIX                            PAGES 
Appendix 1 Permission letter for retrieval data and records’ patient  59 
Appendix 2 Ethical approval from Human Research Ethics Committee  
USM                 60-62 
Appendix 3 Data collection sheet              63-64 
 
 
 
 
 
 
 
 
 
 
 
 
 
ix 
 
A PRELIMINARY STUDY OF RISK FACTOR OF BREAST CANCER AND 
THE USEFULNESS OF BREAST MRI AS AN ADDITION TO 
MAMMOGRAPHY IN DETECTING BREAST CANCER IN HIGH RISK 
WOMEN 
 
ABSTRACT 
The risk factors of breast cancer among women, such as genetic, family history 
and lifestyle factors, can be divided into high, intermediate and average-risk. Screening 
of breast cancer which include mammography, can be done in promoting early breast 
cancer detection. Breast magnetic resonance imaging (MRI) has been recommended as 
a supplemental screening tool in high risk women. Therefore, the aim of this study was 
to identify the significant risk factor(s) of breast cancer among women and also to 
determine the usefulness of breast MRI as an addition to mammography in detection of 
breast cancer in high risk women. This retrospective cohort study design was conducted 
using patients’ data since 2007 until present. Data were taken from those who 
undergone mammography for screening or diagnostic purposes and diagnosed with 
breast cancer in Advanced Medical and Dental Institute, Universiti Sains Malaysia. 
Data from 289 subjects were successfully retrieved and analysed based on their risk 
factors of breast cancer. Meanwhile, data from 120 subjects who have undergone both 
mammography and breast MRI were also analysed. The final results showed that there 
were significant risk factors of breast cancer among the study population; family history 
of breast cancer (p=0.04), HER2 gene mutation (p= 0.006) and previous history of 
breast or ovarian cancer (p=<0.001). Breast MRI showed high sensitivity (90%) while 
mammography showed high specificity (80%) in detection of breast cancer. However, 
breast MRI was found to be non-significant as an adjunct tool to mammography in 
detecting breast cancer in high risk women (p value >0.05). In conclusion, this study 
showed that there were significant risk factors of breast cancer seen among women and 
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there was no statistically significant usefulness of breast MRI as an addition imaging 
modality to mammography in detection of breast cancer in high risk women. 
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KAJIAN AWAL MENGENAI FAKTOR RISIKO KANSER PAYUDARA DAN 
PENGGUNAAN MRI PAYUDARA SEBAGAI MODALITI TAMBAHAN 
KEPADA MAMOGRAFI DALAM PENGESANAN KANSER PAYUDARA 
DALAM KALANGAN WANITA YANG MEMPUNYAI  
FAKTOR RISIKO TINGGI 
 
ABSTRAK 
Faktor risiko kanser payudara dalam kalangan wanita seperti factor genetik, 
sejarah keluarga dan factor gaya hidup seharian, boleh diklasifikasikan sebagai tinggi, 
pertengahan dan biasa. Penyaringan kanser payudara termasuk mamografi boleh 
dijalankan untuk pengesanan awal kanser payudara. Pengimejan resonans magnetik 
(MRI) payudara disyorkan sebagai alat pemeriksaan tambahan dalam kalangan wanita 
yang berisiko tinggi. Sehubungan itu, tujuan utama kajian ini ialah untuk mengenal 
pasti factor risiko yang signifikan terhadap kanser payudara dalam kalangan wanita dan 
juga untuk merungkai penggunaan MRI payudara sebagai modaliti pengimejan 
tambahan kepada mamografi untuk pengesanan kanser payudara dalam kalangan wanita 
yang mempunyai faktor risiko yang tinggi.  Reka bentuk kajian retrospektif kohort ini 
menggunakan data pesakit sejak dari tahun 2007 sehingga sekarang. Data diambil 
daripada subjek yang menjalankan mamografi dengan tujuan penyaringan atau 
diagnostik dan didiagnosa dengan kanser payudara di Institut Perubatan dan Pergigian 
Termaju, Universiti Sains Malaysia. Sejumlah 289 data subjek telah berjaya diperoleh 
berdasarkan kepada faktor risiko kanser payudara yang terdapat pada setiap subjek. 
Sementara itu, data daripada 120 subjek yang menjalankan kedua-dua pengimejan 
mamografi dan MRI payudara juga dianalisa. Hasil akhir yang diperoleh menunjukkan 
bahawa terdapat faktor risiko kanser payudara dalam kalangan wanita yang mempunyai 
sejarah kanser payudara dalam keluarga (p=0.04), mutasi gen HER2 (p= 0.006) dan 
juga sejarah kanser payudara atau ovari (p<0.001). Sementara itu, MRI payudara 
menunjukkan sensitiviti yang tinggi iaitu 90%, manakala mamografi menunjukkan 
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spesifisiti yang tinggi iaitu 80% dalam mengesan kanser payudara. Walau 
bagaimanapun, kegunaan MRI payudara dapat dilihat tidak memberi statistik yang 
signifikan sebagai modaliti pengimejan tambahan kepada mamografi untuk pengesanan 
kanser payudara dalam kalangan wanita yang mempunyai faktor risiko yang tinggi (p 
>0.05). Oleh itu, kajian ini menunjukkan bahawa terdapat beberapa faktor risiko yang 
signifikan untuk kanser payudara dalam kalangan wanita dan penggunaan MRI 
payudara didapati tidak menunjukkan sebarang statistik yang signifikan sebagai 
modaliti pengimejan tambahan kepada mamografi untuk mengenalpasti kanser payudara 
dalam kalangan wanita yang mempunyai faktor risiko yang tinggi. 
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CHAPTER 1 
INTRODUCTION 
 
1.1 Background of the Study 
Approximately 1.4 million women were diagnosed with breast cancer 
worldwide, and nearly 450,000 deaths were recorded in year 2008 (Youlden et al., 
2012). Ultimately, it is the second most common cancer overall and the leading cause of 
cancer mortality among women with estimated 1.67 million new cases diagnosed in 
2012 (Ferlay et al., 2012). Obviously, these data show the climbing pattern of the 
incidence rate of breast cancer worldwide.  
Most health professionals believe that early detection of breast cancer through 
screening save thousands of life each year (American Cancer Society, 2015). 
Recommended screening guideline should be considered for early breast cancer 
detection as most women are asymptomatic when the tumour is small and is easily 
cured at the early stage (Altery et al., 2013). In United States, it is estimated that in 
2015, almost 231,840 incidence of invasive breast cancer and 60,290 incidence of 
carcinoma in situ will be diagnosed. Of these, 40,290 women will be dying from breast 
cancer (American Cancer Society, 2015).  
Meanwhile in Malaysia, breast cancer was reported to be the most common 
cancer in females and also the most common cancer among population despite of sex 
with 3242 female breast cancer cases diagnosed in 2007(Malaysian Cancer Statistics, 
2007). Additionally, breast cancer is the most frequent cancer among Malaysians (18.0 
%), followed by large bowel cancer (11.9%) and lung cancer (7.4%) (Chye et al., 2008).  
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In 2002, there was decrease in breast cancer incidence seen in United States, 
occurring after the highly publicised series by Women’s Health Initiative. This was in 
contrast with the incidence rate among Asian countries which increasingly occur (Pathy 
et al., 2011), proved by the audit done by University Malaya Medical Centre which 
demonstrated the rise in the incidence of breast cancer with 83 cases in 1995, followed 
by 154 cases in 2000 and 340 cases in 2005 (Nur Aisyah Taib et al., 2007). The 
proposed factors for this trend include alteration in reproductive factors, environmental 
exposure, and lifestyle such as dietary intake and physical activity (Pathy et al., 2011). 
1.2 Problem Statement 
Every disease has their own features and risk factors. There is high tendency for 
an individual to get the disease if there is high risk factor seen. Same goes to the risk 
factors of breast cancer which are highly responsible for the increase in the incidence 
rate of breast cancer in women. Yip et al. in 2006 demonstrated that the incidence rate 
of breast cancer in Malaysia, differs among three major races; 1 in 16 Chinese, 1 in 16 
Indian and 1 in 28 women having breast cancer at certain stage in their lifetime which 
were highly related to the lifestyle and reproductive factor (Yip et al., 2006).   
In Western populations, risk factors of breast cancer have been widely 
investigated. Lifestyle-associated and reproductive factors were found to be highly 
correlated with breast cancer (Norsaadah et al., 2005). Breast cancer presentation, stage 
of disease and survival rates by race and ethnicity were highly influenced by 
combination of socioeconomic and lifestyle factors, and possible tumour characteristics 
(Li, et al., 2003). The survival rate for late stage detection of breast cancer was found to 
be worse in Malays followed by Chinese and Indians (Yip et al., 2006).  
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Early detection of breast cancer can be overcome by identifying the risk factors 
and selection of the appropriate screening tool. However, there is less information 
available relating to the risk factors of breast cancer among Asian women (Norsaadah et 
al., 2005). Early detection of breast cancer plays a vital role in improving the survival 
rate among breast cancer in women, and identifying related factors having high 
tendency in getting breast cancer at some stage of their lifetime is essential. Over the 
past few decades, mammography and clinical breast examination were the gold standard 
for screening test for early detection of breast cancer as suggested by American Cancer 
Society. Nowadays, for those women with high risk for breast cancer due to certain 
factor, they are recommended to undergo breast magnetic resonance imaging (MRI) 
which is highly sensitive in detecting breast cancer (American Cancer Society, 2015). 
Ministry of Health in Malaysia plays a major role in health screening program 
and promoting early breast cancer detection among women by breast self examination, 
clinical breast examination and mammography (Yip et al., 2006) especially for those 
with high risks. This is important for early diagnosis and treatment of breast cancer and 
subsequently for better quality of life.  
As well as the appropriate screening tool, Western countries are widely 
investigating the effectiveness of breast MRI in detection of breast cancer in women 
with high risk. By far, breast MRI appears to be more sensitive than mammography in 
detecting breast cancer among women with high risk (Kriege et al., 2004). However in 
Malaysia, no studies have been done in looking at the effectiveness of breast MRI as 
adjunct tool to mammography in detection of breast cancer. To date, this is the first 
study to be conducted in northern Malaysia to identify the risk factors of breast cancer 
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and also the efficacy of breast MRI as an addition to mammography in detecting the 
breast cancer in high risk women. 
1.3 Research objectives 
1.3.1 General Objective 
To study the risk factors of breast cancer and the usefulness of breast MRI as an 
addition to mammography in detecting breast cancer in high risk women. 
1.3.2 Specific Objectives 
(a) To identify the significant risk factor of breast cancer in women 
(b) To determine the usefulness of breast MRI as an addition to mammography in 
detecting breast cancer in high risk women 
1.4 Research Questions 
(a) What is the significant risk factor of breast cancer in women? 
(b) Is there any role of breast MRI as an addition to mammography in detecting 
breast cancer in high risk women? 
1.5 Research Hypothesis 
(a) Null hypothesis, H˳ : There is no significant association between risk factors and 
breast cancer 
Alternative hypothesis, HA: There is significant association between risk factors 
and breast cancer. 
(b)  Null hypothesis, H˳: Breast MRI is not useful imaging modality as an addition 
tool to mammography in detecting breast cancer in high risk women. 
Alternative hypothesis, HA: Breast MRI is useful imaging modality as an 
addition tool to mammography in detecting breast cancer in high risk women. 
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1.6 Significance of the Study 
In Malaysia, risk factors of breast cancer among women are not widely 
investigated yet. There is lack of information regarding which risk factor is significant 
for Malaysian women in developing this disease. Even though the risk factors of breast 
cancer in Western countries have been well investigated, there should be differences 
seen in Malaysian women as there are differences in lifestyle habit, socioeconomic 
status and dietary habit.  
In fact, the incidence report of newly diagnosed breast cancer in Western 
countries is decreasing due to continuous health awareness programme held. In contrast, 
in Asian countries, the incidence report of newly diagnosed breast cancer is increasing, 
suggesting the lack of knowledge and information, accessibility of the facilities of 
screening program as well as inadequate health awareness programme in our 
population. Therefore, this study is important to identify significant risk factors of 
breast cancer among women in Malaysia, in particular the northern Malaysia. New 
information gained will be beneficial and can be implemented effectively in health 
screening and health awareness programmes in promoting early breast cancer detection 
In addition, appropriate screening tool plays a vital role especially in detecting 
high risk of breast cancer among women. Studies showed that mammography is the first 
line screening tool besides breast self examination and clinical breast examination. 
However, mammography alone is inadequate in diagnosing breast cancer. Therefore, 
breast MRI is found to be a sensitivity imaging tool towards detection of breast cancer 
in the images produced. Breast MRI was suggested in women with high risk of breast 
cancer after screening by mammography. Therefore, the aim of this study is to 
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determine the usefulness of breast MRI as an addition to mammography in high risk 
women in detecting breast cancer.  
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CHAPTER 2 
LITERATURE REVIEW 
2.1 Introduction 
Cancer is mutated cells in the body which can grow and form a tumour, named 
after the part of the body where it originates (Altery et al., 2013). Breast cancer is a type 
of cancer that forms from breast tissues, potentially to be malignant and can invade the 
surrounding cells and metastasise to distant organs (American Cancer Society, 2015). 
Basically, breast cancer has five stages; Stage 0 (carcinoma in situ which does 
not spread to other tissues beside breast), stage 1 (subdivided into stage 1A and 1B 
based on the size of the tumour - less than 2cm with no lymph node involvement), stage 
II (subdivided into stage IIA and IIB based on the size of the tumour - 2cm to 5cm and 
with/without lymph nodes involvement), stage III (subdivided into IIIA, IIIB and IIIC 
based on the size of the tumour - more than 5cm and spreads to axillary lymph nodes, 
overlying skin or chest wall) and stage IV (cancer spreads to other organs e.g. lungs, 
liver or brain) (National Cancer Institute, 2015).  
However, all of these stages of breast cancer can be determine by screening 
through appropriate screening tool and need to be investigated thoroughly by health 
professionals. In addition, early detection as well as early treatment of breast cancer can 
be implemented by identifying the risk factors that are related to breast cancer which 
can help in preventing late stage detection of breast cancer. The survival rate for late 
stage detection is worse than early detection (Yip et al., 2006). 
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2.1.1 Risk factors of Breast Cancer 
According to the American College of Radiology, women with high risk of 
breast cancer have 20% or greater risk in getting breast cancer in their lifetime, whereas 
those with intermediate risk have 15% to 20% lifetime risk of breast cancer and of those 
with average risk, less than 15% lifetime risk of breast cancer (Maineiro et al., 2013). 
There are several risk factors of breast cancer which can be classified into genetic, 
family history and lifestyle factors (Tyrer et al., 2004). Genetic factors include mutation 
of breast cancer gene (BRCA 1 and BRCA 2) (Martin and Weber, 2000), Human 
Epidermal Growth Factor Receptor 2 (HER2) mutation (Yang et al., 2007) and Tumour 
protein p53 (p53) mutation (Miler et al., 2005). Meanwhile, family history can be 
subdivided into family history of breast cancer (Colditz et al., 1996) and family history 
of ovarian cancer (Mcpherson et al., 2000). Personal history or lifestyle factors include 
previous history of breast cancer, previous history of atypia on breast biopsy 
(Singletary, 2003), current treatment with hormone replacement therapy (HRT), 
previous radiation therapy to chest or breast area, nulliparity, delivery at age more than 
30 years, first menarche before the age of 12 years, body mass index (BMI) more than 
30 and smoking (Mcpherson et al., 2000). 
Recently, two known genes with high susceptibility in developing breast cancer 
have been widely investigated. These genes of BRCA1 and BRCA2 have been 
identified as having a germ line mutation accountable for between 5% and 10% of all 
breast cancer (Martin and Weber, 2000). Some women that carry these mutations 
underwent mastectomy or oophorectomy as the cancer risk was very high (Antoniou et 
al., 2003).  Predictive testing have been widely done for screening mutation in these 
genes and more than 750 protein truncating mutation within these genes have been 
identified. Additionally, somatic mutation has been identified at the p53 genes which 
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give a high percentage of susceptibility to get breast cancer (Sirandsky et al., 1992). 
Although the frequency of genetic mutation at the p53 genes is lower than others solid 
tumour, molecular pathological study of the structure and expression of the p53 
pathway are able to generate value in diagnosis, prognosis and treatment of breast 
cancer (Gasco et al., 2002). Besides that, it has been estimated that 1 in 5 patients with 
breast cancer has numerous HER2 receptor on the surface of the cells which are also 
known as growth promoting protein leading to aggressive spread of the cancer disease 
(American Cancer Society, 2015) 
Family history of breast cancer is an established risk factor for breast cancer 
among women (Colditz et al., 1996). In Malaysia, study in Kelantan showed that 
nulliparity and family history were well established risk factors of breast cancer among 
women whereas the correlation of oral contraceptive and obesity with breast cancer was 
still unclear (Yip et al., 2006). Meanwhile, Martin and Weber demonstrated that 
estrogen exposure was directly associated with risk factor of breast cancer and related to 
age of menarche, nulliparity and late onset of menopause (Martin and Weber, 2000). In 
addition, risk factors of breast cancer such as age and postmenopausal hormone usage 
differed according to Estrogen Receptor status and at the same time, reproductive 
history and BMI after menopause differed according to Progesterone Receptor status 
(Colditz et al., 2004). In fact, study done by Yip et al., in 2006 showed that almost 
55.7% of all studied cases were found to be Estrogen Receptor positive (Yip et al., 
2006). These data demonstrated that the incidence of breast cancer is highly related to 
estrogen level among women. Additionally, it was proven by the studies shown that 
repeated estrogen exposure would lead to development of breast cancer (Martin and 
Weber, 2000). Differences in exercise and dietary intake of certain nutrients may also 
influence exposure to estrogen (Clemons et al., 2001). Several studies also showed that 
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nulliparity, late age at first birth, as well as obesity among postmenopausal women were 
strongly linked to estrogen and progesterone receptor positive and prone to cause breast 
cancer (Yang et al., 2007). 
2.1.2 Screening tools of Breast Cancer 
Screening of breast cancer can be done before the symptoms or after the 
symptoms have developed such as breast lump (Altery et al., 2013). Mammography 
screening is the gold standard as first line screening and diagnostic tool for breast 
cancer. Recently, breast MRI has been widely investigated, demonstrating high 
sensitivity in early detection of breast cancer. There was recommendation for breast self 
examination, clinical breast examination and mammography in those with high risk of 
breast cancer in early detection of the disease (Coldit et al., 1996). Compared to 
mammography or even combination of mammography with high frequency ultrasound, 
breast MRI did not demonstrate essential role in early diagnosis of familial breast 
cancer (Kuhl et al., 2005).  Generally, women with breast cancer are asymptomatic and 
thus, it is vital for women to follow recommended screening guidelines for the detection 
of breast cancer at an early stage (Altery et al., 2013). Despite that, women with 
genetically inherited breast cancer often developed the disease at young age and the 
dense breast tissues reduced the sensitivity of mammography in detecting lesions 
(Magnetic Resonance Imaging in Breast Screening (MARIBS), 2005). Therefore, there 
was strong evidence that breast MRI should be included in breast cancer screening 
programs for young high risk women in detection of breast cancer compared to 
conventional screening strategies (Lord et al., 2007).  
According to American College of Radiology, mammography screening can be 
done as early age of 25 to 30 years old or 10 years before age of first-degree relative 
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with breast cancer or 8 years after radiation therapy and both mammography and breast 
MRI are complementary examinations that should be performed (Maineiro et al., 2012). 
Additionally, screening breast MRI was recommended for women with an 
approximately 20 to 25% or greater lifetime risk to get breast cancer including women 
with a strong family history of breast or ovarian cancer and women who were treated 
for Hodgkin disease (Kuhl et al., 2005). It was suggested that more frequent screening 
should be needed for women with genetic mutation of BRCA 1, BRCA2, phosphatase 
and tensin homolog, and p53 as larger tumours more than 2cm were found more often 
in these women (Kriege et al., 2004). Besides that, MRI was found to be significantly 
high in sensitivity in detecting intraductal and invasive familial or hereditary breast 
cancer (Kuhl et al., 2005). 
However, the cost in performing breast MRI is more as compared to 
mammography. Mammography is fairly cheap and widely available. However, breast 
MRI was found to be potentially cost-effective for screening women younger than 
50years with high risk of breast cancer (Lord et al., 2007). Contrast enhancement MRI 
was found to be the new screening tool that gave more benefits in carriers of BRCA1 
germ line mutations (MARIBS, 2005). 
There is limitation in detecting breast cancer in younger women with high risk of 
breast cancer due to their dense breasts. Therefore, breast MRI is the appropriate 
screening tools and as reported, breast MRI was able to detect mammographically 
occult breast cancer in women at high risk (Lehman et al., 2005).  
In conclusion, several studies suggested that breast MRI can help in detection of 
breast cancer in high risk women and help in early detection of breast cancer. However, 
there is still a need in investigating the usefulness of breast MRI as an addition to 
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mammography in high risk women. Furthermore in Malaysia, there are limited studies 
available related to this research which can potentially give a lot of benefits to public 
health as well as improvement to quality of care. 
2.2 Theoretical Framework 
The Health Belief Model (HBM) is a psychological model that attempts to 
explain and predict health behaviours. This is done by focusing on the attitudes and 
beliefs of individuals. The HBM was first developed in the 1950s by social 
psychologists Hochbaum, Rosenstock and Kegels working in the United States of 
America Public Health Services (Janzand Becker, 1984). The HBM suggests that a 
person's belief in a personal threat of an illness or disease together with a person's belief 
in the effectiveness of the recommended health behaviour or action will predict the 
likelihood the person will adapt to the behaviour. Based on this study, this model helps 
in explaining the seeking behaviour to get medical attention as well as initiative to do 
screening and diagnostic test for early detection of breast cancer. In HBM, it predicts 
that women will likely to adhere to screening mammography recommendations if they 
feel susceptible to breast cancer, think breast cancer is a severe disease, perceived 
barriers to screening as lower than perceived benefits, have higher self-efficacy for 
obtaining mammograms and receive cue to action (Fulton et al., 1991). Figure 2.1 
shows basic element of HBM. Meanwhile Table 2.1 shows modified from Key concepts 
and definition of health belief models. 
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Figure 2.1: Basic elements of health believe models (Janz and Becker, 1984, 
The Health Believe Model: A Decade Later) 
 
 
 
 
 
 14 
 
 
Table 2.1:Modified from Key concepts and definition of health belief models 
(Fulton et al., 1991, ―A study guided by the Health Belief Model of the predictors of 
breast cancer screening of women ages 40 and older‖). 
 
 
 
 
Concept  Definition  Application 
Perceived 
Susceptibility 
Belief about the chances of 
experiencing a risk or getting 
a condition or disease 
Women with either risk factors of  
family history of breast or ovarian 
cancer; gene mutation; previous 
history of atypia; previous history 
of breast or ovarian cancer; 
hormone replacement therapy; 
nulliparity; radiation; menarche at 
age less than 12 years old or 
BMI<30 believe about the chances 
to have breast cancer 
Perceived 
Severity 
Belief about how serious a 
condition and its sequelae are 
Have chances to get breast cancer 
in whatever stages in lifetime 
Perceived 
Benefits 
Belief in efficacy of the 
advised action to reduce risk  
or seriousness of impact  
Undergone screening or diagnostic 
test such as mammogram and/or 
MRI breast for early detection of 
breast cancer 
Perceived 
Barriers  
Belief about the tangible and  
psychological costs of the  
advised action 
The test suggested is depend on the 
degree of the seriousness of the 
illness according to the physician 
Cues to 
Action  
Strategies to activate 
―readiness‖ 
Frequently do breast self 
examination and yearly 
mammogram screening test to alert 
any abnormalities 
Self-Efficacy  Confidence in one’s ability to  
take action 
Moral support and encouragement 
from family members is needed to 
take the action. 
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CHAPTER 3 
RESEARCH METHODOLOGY 
3.1 Research Design 
This study was conducted using quantitative, retrospective and cohort study 
design in order to identify the significant risk factor of breast cancer among women, as 
well as to determine the usefulness of using breast MRI in high risk women as an 
addition to mammography. The study was conducted over a period of eight months 
starting from April 2015 until November 2015. 
3.2 Population and Setting 
The study was conducted at Advanced Medical and Dental Institute (AMDI), 
UniversitiSains Malaysia (USM). The study populations were women who came to 
AMDI for screening or diagnostic mammography since August 2007 until present. 
3.3 Sampling plan 
3.3.1 Sample 
3.3.1.1 Inclusion Criteria 
1. Female age > 25 years old 
2. Women with either high, intermediate or average risk of breast cancer. 
3. Women who had undergone mammography alone or mammography and breast 
MRI. 
4. Available histopathological examination (HPE) results for women who were 
diagnosed with benign breast lesion or breast cancer. 
3.3.1.2 Exclusion Criteria 
1. Women who have psychological disorder. 
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3.3.2 SamplingMethod 
Probability sampling method i.e. simple random sampling was used in this 
study. All selected women were classified as high, intermediate or average risk for 
breast cancer and undergone mammography or breast MRI and mammography 
examinations. 
. 
3.3.3 Sample Size 
The calculation of sampling size was done by using Raosoft method. The margin 
error used in this calculation is 5%. The margin of error is the amount of error which 
can be tolerated. Lower margin of error requires a larger sample size. In addition, 95% 
of confident interval (CI) level used in this calculation. 
Higher confidence level requires a larger sample size. Response distribution 
used was 50%. From calculation of the sample size, the population size used in this 
study was 289 respondents. 
Calculation method:  
x=Z(
c
/100)
2
r(100-r) 
n=
N x
/((N-1)E
2
 + x) 
E=Sqrt[
(N - n)x
/n(N-1)] 
Where, 
n = the sample size  
E= margin of error  
N= the population size, 
r = Fraction of responses of interest 
Z(c/100) = Critical value for the confidence level c.  
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3.4 Variable 
3.4.1 Variable measurement 
The independent variable in this study was the risk factors of breast cancer 
which include family history of breast cancer, family history of ovarian cancer, HER2 
mutation, p53 mutation, previous history of atypia on breast biopsy, previous history of 
breast cancer or ovarian cancer, currently on HRT, previous radiation therapy (breast or 
chest area), nulliparous, first menarche before the age of 12 and BMI of more than 30. 
Meanwhile, the dependent variable was the detection of breast lesion whether it was 
benign or malignant. 
Besides that, the usefulness of breast MRI was determined by using specificity 
and sensitivity method calculation in contingency table. 
3.5 Instrumentation 
Using quantitative, retrospective and cohort study design, all data kept since 
August 2007 were collected from the Imaging Unit, as well as Data and Records Unit of 
AMDI. All women who came to AMDI were firstly classified into which risk factors 
they have based on the checklist provided by Imaging Unit, AMDI. The mammography 
examination form comprised of selected demographic data, clinical history, hormonal 
status, clinical signs, physical examination findings, radiographer’s finding and 
radiologist’s report.    
 
 18 
 
3.6 Ethical Considerations 
Ethical aspect for research study is important and acts as a baseline for research 
to be conducted in the right way. For this study, the ethical consideration includes the 
approval from the Human Research Ethics Committee USM. The letter of requesting 
permission was sent to them prior to the conduct of the study and started only after 
receiving the written approval. In addition, the data obtained from those who were 
included in this study would be confidential and strictly used for the purpose of this 
study only. 
3.7  Data Collection Methods 
The data was collected from the AMDI mammography audit system that was 
kept since August 2007 until present. The data collection was conducted a month after 
the approval from Human Research Ethics Committee USM.  
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3.7.1 Flow chart of Data Collection 
 
 
 
Figure 3.1: Flow Chart of Data Collection 
 
 
 20 
 
3.8 Data Analysis 
The data collected was analysed using Statistical Package for Social Science, 
SPSS version 22. Descriptive statistic was used to summarise the risk factors of breast 
cancer mentioned earlier. Besides that, the logistic regression analysis was used to 
determine the significant risk factors (independent) of breast cancer (dependent). 
Meanwhile, sensitivity and specificity testing was used to determine the efficacy of 
breast MRI as an addition to mammography in high risk women while the usefulness of 
breast MRI as an addition to mammography was determine by contingency table and 
Pearson Chi Square test. 
A 5% error in rejecting null hypothesis with 95% CI was used. Significant level 
was defined as p <0.05. 
3.9      Definition of Operational Term 
3.9.1 Independent Variables (Risk Factors) 
Risk factor is any attribute, characteristics or exposure of an individual that 
increases the likelihood of developing a disease or injury [World Health Organisation 
(WHO), 2015]. There is also an aspect of personal behaviour or lifestyle, an 
environmental exposure, or an inborn or inherited characteristic associated with an 
increase likelihood of disease or other health-related event or condition, a variable that 
affects the probability of a specified adverse event (Segen’s Medical Dictionary, 2011). 
Risk factors for breast cancer can be classified into three major part; high risk of breast 
cancer (women had 20% or greater in their lifetime risk to get the breast cancer), 
intermediate risk (women had 15% to 20% lifetime risk of breast cancer) and average 
risk (women had less than 15% lifetime risk of breast cancer) (Maineiro et al., 2013).   
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Below are the risk factors that were included in this study: 
1. Family history of breast cancer 
a) Mother, sisters or daughters even had breast cancer before the age of 50 
years 
b) Two or more maternal or paternal relatives ever had breast cancer 
(grandmother, aunt, niece) 
2. Family history of ovarian cancer 
a) Mother, sisters or daughters even had ovarian cancer before the age of 50 
years 
b) Two or more maternal or paternal relatives ever had ovarian cancer 
(grandmother, aunt, niece) 
3. Genetic mutation 
a) HER2 mutation 
b) p53 mutation 
4. Previous history of atypia on breast biopsy 
e.g. Lobular carcinoma in situ and atypical hyperplasia 
5. Previos history of breast cancer or ovarian cancer 
6. Currently on hormone replacement therapy 
7. Previous radiation therapy (to breast / chest area) 
8. Nulliparous or deliver after the age of 30 
9. First menarche before the age of 12 
10. Body mass index of more than 30 
 
3.9.2 Dependent Variables 
1. Mammography result 
Mammography is the radiographic examination soft tissue of the breast. It is 
used to identify various benign and malignant neoplastic processes (Mosby’s Medical 
Dictionary, 2008). Annual screening for mammography is recommended at the age of 
40 years old for general population, at age 25 to 30 years old for BRCA carriers and at 
age 25 to 30 years or 10 years earlier for women with a first-degree relative having 
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premenopausal breast cancer or for women with a lifetime risk of breast cancer ≥20% 
on the basis of family history (Maineiro et al., 2013). In this study, mammography 
result was classified into Breast Imaging Reporting and Data System (BI-RADS) 
category, negative and positive finding. The BI-RADS category was the standard 
measurement of imaging modalities. Meanwhile, negative and positive finding were the 
results of cancer detection based on HPE finding. 
2. Breast MRI result 
MRI is a non-invasive diagnostic technique that uses nuclear magnetic 
resonance to produce cross-sectional images organ and other internal body structures. 
Several studies showed that breast MRI was recommended for women with high risk of 
developing breast cancer due to its higher sensitivity than mammography (Maineiro et 
al., 2013). In this study, breast MRI results were also classified into BI-RADS category, 
negative and positive findings. The BI-RADS category was the standard measurement 
of imaging modalities. Meanwhile, negative and positive findings were the results of 
breast cancer detection based on HPE finding. 
3. Breast lesion detection (benign or malignant) 
Benign cells are non-cancerous cells that do not invade other cells while 
malignant cells are cancer cells that are made up of cells that grow out of control. Breast 
cancer is caused by the development of malignant cells in the breast (Breastcancer.org., 
2015). The malignant cells originate in the lining of the milk glands or ducts of the 
breast (ductal epithelium), defining this malignancy as a cancer. Cancer cells are 
characterised by uncontrolled division leading to abnormal growth and the potential of 
these cells to intrude into normal tissue locally or to spread throughout the body which 
is also known as metastasis (Gale Encyclopedia of Medicine, 2008). 
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CHAPTER 4 
RESULTS 
4.1 Sociodemographic Data 
Data was collected from 289 female subjects (representing 100% of total sample 
size) who underwent screening or diagnostic mammography and diagnosed with breast 
cancer in AMDI. The average age ± standard deviation (SD) was 54.77 ± 11.26 years 
(age range, 31 to 92 years). Of the 289 subjects included, 278 (96.2%) were married or 
divorce and majority was Malay (50.9%), followed by Chinese (36.7%) and Indian 
(12.5%) following the normal race distribution in this country. The baseline 
demographic data in the study population is shown in Table 4.1. 
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Table 4.1: Demographic data of study subjects (n=289) 
Demographic Data Mean (SD) Frequency Percentage (%) 
Age 
 
Marital Status 
Single 
Married/divorce 
 
Race 
    Malay 
    Chinese 
    Indian  
54.77 (11.26)  
 
 
11 
278  
 
 
147 
106  
36  
 
 
 
3.8 
96.2 
 
 
50.9 
36.7 
12.5 
 
 
 
 
 
 
 
 
 
 
